No Data
Cosmos Pharmaceuticals, Nomura Securities has raised the Target Price to 11,100 yen.
On the 28th, Nomura Securities maintained the investment rating of Cosmos Pharmaceutical <3349.T> as "Buy". The Target Price was raised from 10,800 yen to 11,100 yen, expecting continued profit expansion due to improvements in gross profit margin. Provided by Wealth Advisor Inc.
Kandenko, Amano ETC (Additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous Change After----------------------------------------------------------------- <4626> Taiyo HD Morgan S "Equal W" "Over W" <8308> Resona HD Nomura "Neutral" "Buy" Target Price Change Code Stock Name Securities Company Previous Change After-------------------------------------
Rating information (Target Price change - Part 1) = Kansai Electric Power, Amano, ETC.
◎Nomura Securities (3-tier; Buy > Neutral > Reduce) Kansai Electric Power <1942.T> --- "Buy" → "Buy," 3,300 yen → 3,480 yen Cosmos Pharmaceutical <3349.T> --- "Buy" → "Buy," 10,800 yen → 11,100 yen Ryohin Keikaku <7453.T> --- "Buy" → "Buy," 4,500 yen → 5,100 yen Sekisui Chemical <4204.T> --- "Neutral" → "Neutral," 2,600 yen → 2,610 yen OLC <4661.T> --- "Neutral"
Stocks that moved and those that were traded in the front market.
*Nova Ltd <9519> 654 +49, upward revision of performance to reduce profit decline. *Nomura Micro Science <6254> 2360 +170, expected increase in year-end Dividends. *Sumitomo Electric Industries <5802> 2244 +163, riding the trend of rising Autos-related stocks. *Musashi Seimitsu Industry <7220> 2333 +160, funds are also moving toward Datacenter-related due to the rise in Semiconductors stocks. *Osaka Titanium Technologies <5726> 1624 +109, Boeing's increased production plan.
Express News | 【Large Shareholding Report】Baillie Gifford and Company reports a 6.42% Shareholding in Cosmos Pharmaceuticals (3349.JP).
Express News | [Change Report] JP Morgan Asset reported an increase in Shareholding in Cosmos Pharmaceuticals (3349.JP) to 5.94%.
